Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its Board

10.04.2024 - STOCKHOLM, SWEDEN / ACCESSWIRE / April 10, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB ('AlzeCure' or 'the Company'), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and ...

Related Keywords

Uppsala ,Uppsala Lan ,Sweden ,Swedish ,Alzecure Pharma ,Jan Lundberg ,Faculty Of Pharmacology At Uppsala University , ,Uppsala University ,Nasdaq First North Premier Growth Market ,Alzecure Pharma Stock ,Alzecure Pharma Chart ,Lzecure Pharma Kurs ,Lzecure Pharma Aktie ,